The success of Sildenafil initially fueled a boom for pharma, however recent shifts present a complicated picture for those considering a stake. Off-patent competitors are reducing profits, and persistent patent https://caoimhebnjn780931.ampedpages.com/sildenafil-and-big-pharma-a-risky-play-68186290